November 22, 2016 - By Adrian Mccoy · 0 Comments
Nov 22 is a positive day so far for Direxion Daily S&P Biotech Bear 1X ETF (NYSEARCA:LABS) as the ETF is active during the day after gaining 1.09% to hit $36.92 per share. The exchange traded fund has 6.60 million net assets and 0.72% volatility this month.
Over the course of the day 1,024 shares traded hands, as compared to an average volume of 940 over the last 30 days for Direxion Daily S&P Biotech Bear 1X ETF (NYSEARCA:LABS).
The ETF is -39.60% of its 52-Week High and 2.60% of its low, and is currently having ATR of 0.91. This year’s performance is -7.84% while this quarter’s performance is -8.88%.
The ETF’s YTD performance is 4.33%, the 1 year is NaN% and the 3 year is NaN%.
The fund’s top holdings are: S&P Biotechnology Select Industry USD for 89.80% of assets, Fidelity Institutional Go for 18.89%, S&P Biotechnology Select for 12.54%.
More notable recent Direxion Daily S&P Biotech Bear 1X Shares (NYSEARCA:LABS) news were published by: Benzinga.com which released: “Don’t Get SICK Of Healthcare ETFs And Stocks; Try This Instead” on November 15, 2016, also Etftrends.com with their article: “How to Hedge Market Turns with Inverse ETFs” published on June 29, 2016, Marketwatch.com published: “Mr. Trump Goes To Washington” on November 15, 2016. More interesting news about Direxion Daily S&P Biotech Bear 1X Shares (NYSEARCA:LABS) were released by: Benzinga.com and their article: “A New Bearish Biotech ETF And A Lazarus Act For A Couple Leveraged Funds” published on December 03, 2015 as well as Nasdaq.com‘s news article titled: “ETFs to Play as Biotech Juggles Election & Earnings” with publication date: October 17, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Adrian Mccoy